Last 349.00 GBp
Change Today -27.00 / -7.18%
Volume 17.7K
IDH On Other Exchanges
Symbol
Exchange
London
OTC US
Stuttgart
As of 11:35 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

immunodiagnostic systems hld (IDH) Snapshot

Open
360.00 GBp
Previous Close
376.00 GBp
Day High
376.00 GBp
Day Low
347.50 GBp
52 Week High
02/20/14 - 593.00 GBp
52 Week Low
09/17/14 - 347.50 GBp
Market Cap
101.9M
Average Volume 10 Days
6.6K
EPS TTM
0.24 GBp
Shares Outstanding
29.2M
EX-Date
07/23/14
P/E TM
14.5x
Dividend
9.44 GBp
Dividend Yield
2.71%
Current Stock Chart for IMMUNODIAGNOSTIC SYSTEMS HLD (IDH)

Related News

No related news articles were found.

immunodiagnostic systems hld (IDH) Related Businessweek News

No Related Businessweek News Found

immunodiagnostic systems hld (IDH) Details

Immunodiagnostic Systems Holdings PLC, together with its subsidiaries, develops and supplies immunoassay kits and automated immunoanalyser technologies for use in research, medical, and pharmaceutical applications worldwide. The company offers immunodiagnostic kits for use in the investigation of bone, cartilage, growth, and hypertension areas, as well as calcium metabolism and chronic kidney disease; and distributes a range of antibodies, enzymes, and peptides for various specialty areas, including oncology, inflammation, neuroscience, and fertility. It also provides IDS-iSYS, an automated immunoassay system. The company is headquartered in Boldon, the United Kingdom.

328 Employees
Last Reported Date: 06/23/14

immunodiagnostic systems hld (IDH) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 387.0K GBP
Group Finance Director and Director
Total Annual Compensation: 223.0K GBP
Executive Officer of North American Operation...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

immunodiagnostic systems hld (IDH) Key Developments

Immunodiagnostic Systems Holdings Seeks Acquisitions

Immunodiagnostic Systems Holdings plc (AIM:IDH) is seeking acquisitions. Patrik Dahlen, Chief Executive Officer of Immunodiagnostic Systems Holdings, said, “We continue to pursue complementary acquisitions that will help us grow our specialist endocrinology menu and build operational excellence."

Immunodiagnostic Systems Holdings plc Announces Dividend Proposal for the Year Ended March 31, 2014, Payable on August 22, 2014; Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2014

Immunodiagnostic Systems Holdings plc announced that its Board is proposing a dividend of 8.5 pence for the year ended March 31, 2014 compared to 3.0 pence paid for the year 2013. The dividend is subject to the approval of shareholders at the Annual General Meeting on August 4, 2014.  If approved, the dividend will be paid on 22 August 2014 to shareholders on the register at the close of business on 25 July 2014. The company reported audited consolidated earnings results for the year ended March 31, 2014. For the year, the company reported revenue of GBP 52,263,000 compared to GBP 49,772,000 a year ago. Profit before tax was GBP 8,335,000 compared to GBP 10,037,000 a year ago. Profit for the year attributable to owners of the parent was GBP 6,953,000 or 23.7 pence diluted per share compared to GBP 7,779,000 or 27.2 pence diluted per share a year ago. Net cash from operating activities was GBP 12,289,000 compared to GBP 18,356,000 a year ago. Purchases of other intangible assets were GBP 3,698,000 compared to GBP 2,256,000 a year ago. Purchases of property, plant and equipment were GBP 2,226,000 compared to GBP 2,639,000 a year ago. Adjusted EBIT increased to GBP 10.1 million compared to GBP 9.8 million a year ago. Adjusted basic EPS before exceptional items of 28.7 pence compared to 27.2 pence a year ago.

Immunodiagnostic Systems Holdings plc, Annual General Meeting, Aug 04, 2014

Immunodiagnostic Systems Holdings plc, Annual General Meeting, Aug 04, 2014., at 14:00 GMT Standard Time. Location: 10 Didcot Way, Boldon Business Park, Boldon. Agenda: To consider the dividend for the year ended March 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDH:LN 349.00 GBp -27.00

IDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDH.
View Industry Companies
 

Industry Analysis

IDH

Industry Average

Valuation IDH Industry Range
Price/Earnings 15.7x
Price/Sales 2.1x
Price/Book 1.3x
Price/Cash Flow 15.6x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNODIAGNOSTIC SYSTEMS HLD, please visit www.idsplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.